New York · London · Sydney
Get Started on Your Award
Custom crystal commemorating the submission of a New Drug Application (NDA) to the FDA. The application for Impel NeuroPharma’s migraine treatment INP104 was supported by a Phase 3, open-label safety and tolerability trial. (20ALJ356)
"*" indicates required fields
ESPN's annual ESPY Awards telecast has always had a special significance for us at Prestige Custom Awards. It's long been a point of pride for us that we provide the actual awards presented at what is ordinarily a festive, celebratory...
With the run-up to Super Bowl LV on Sunday, February 7th, we thought we'd update a post focusing on a Lucite embedment that resulted from an earlier Super Bowl game. No, the Philadelphia Eagles won't be going to the game this year; but the Kansas...
Recognizing the invaluable contributions of volunteers and donors is crucial for any non-profit organization. These dedicated individuals play a pivotal role in advancing your organization's mission, often going above and beyond to support your...
